Ember Therapeutics Inc - ESG Rating & Company Profile powered by AI
The Sustainability score for Ember Therapeutics Inc represents its reporting of the UN Sustainable Development Goals. Detailed ESG assessment of Ember Therapeutics Inc can be accessed by logging in. The report of Ember Therapeutics Inc leverages intelligence from across the web and also from public filings by Ember Therapeutics Inc.
Ember Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2747 | Aphria Inc | 0.3 | Low |
| 2747 | Sichuan Languang Development Co Ltd | 0.3 | Low |
| 2749 | Ember Therapeutics Inc | 0.0 | Low |
| 2749 | Alpha Group Industries Inc | 0.0 | Low |
| 2749 | BNC Korea Co Ltd (Pre-Merger) | 0.0 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ember Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ember Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Ember Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ember Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Ember Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ember Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ember Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Ember Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ember Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ember Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ember Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ember Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ember Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ember Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Ember Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Ember Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ember Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ember Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Ember Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company focuses on the clinical application of bone morphogenetic protein-7 (BMP-7) to develop regenerative medicines for the disease modification of osteoarthritis (OA), reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases, such as chronic kidney disease (CKD) and Alport's syndrome, as well as metabolic diseases, including obesity and type 2 diabetes. Its lead BMP-7 product candidates include MT-006, which has completed Phase 2a clinical trial for targeting OA; MT-007 that has completed Preclinical trial for CKD and Alport syndrome; MT-008, a Preclinical trial completed candidate for Alport syndrome; and MT-009, a Preclinical trial completed candidate for metabolic disease. The company also holds approximately 450 patents covering BMP-7 and its related family of BMPs, variants, novel formulations, delivery technologies, associated clinical data, and manufactured material with current good manufacturing practice. Ember Therapeutics, Inc. was founded in 2010 and is headquartered in New York, New York.